EMILY PYNE: Open Payments
NPI 1619458189 · ELLICOTT CITY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 51 payments from 15 companies in 2025. Trend: 2023 $520 · 2024 $660 · 2025 $1,001
Food & beverage: $1,001
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $276 |
| ABBVIE INC. | 11 | $182 |
| Organon LLC | 8 | $106 |
| Lilly USA, LLC | 3 | $71 |
| GENZYME CORPORATION | 3 | $66 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| Alexion Pharmaceuticals, Inc. | 2 | $43 |
| Incyte Corporation | 2 | $36 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $36 |
| Amgen Inc. | 2 | $35 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, TALTZ, OPZELURA, Cabtreo, OTEZLA.
Industry payments across MD — which companies pay providers there.
